Wellcome Trust Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
University of Dundee Featured PhD Programmes
University of Edinburgh Featured PhD Programmes
University of East Anglia Featured PhD Programmes
"screening"×
10 miles

screening PhD Projects, Programs & Scholarships

We have 164 screening PhD Projects, Programs & Scholarships

  • "screening" ×
  • clear all
Order by 
Showing 1 to 30 of 164
  Investigating the potential psychological impact of early screening and long-term monitoring for adolescent idiopathic scoliosis among patients and caregivers
  Dr K Kwan
Applications accepted all year round

Funding Type

PhD Type

Scoliosis is a three-dimensional deformity of the spine. The commonest form, adolescent idiopathic scoliosis (AIS) develops in puberty and may progress during adolescence.
  Development of novel macrophage high-throughput cell-based phenotypic assay for drug screening
  Research Group: Biomedical Research Group
  Dr G Pirianov, Prof S Cellek
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  How do we achieve routine alcohol screening in inpatient mental health settings? (KhadjesariZU19SF)
  Dr Z Khadjesari, Prof K Sanderson
Application Deadline: 31 May 2020

Funding Type

PhD Type

Background. Improving the physical health of people with mental illness is a priority for the NHS. Compared with the general population, alcohol consumption among people with a mental illness is three times higher, yet people with mental illness have comparatively limited access to physical healthcare services.
  PhD Studentship in Rapid Ionic-liquid Screening for Enhanced Recycling Screening (RISERS)
  Dr A Brandt-Talbot, Prof P Fennell
Applications accepted all year round

Funding Type

PhD Type

We are inviting applications of motivated candidates for a PhD studentship in the exciting global challenge of ‘Advanced plastic recycling’.
  (MCRC Clinical) Urinary HPV testing for cervical cancer screening
  Prof E Crosbie, Prof T Walsh
Application Deadline: 1 December 2019

Funding Type

PhD Type

Background. Cervical cancer is caused by chronic infection with human papillomavirus (HPV). Cervical screening tests for HPV in cells collected from the cervix using a soft brush.
  Simultaneous use of genetic and non-genetic information in the evaluation of screening and diagnostic testing pathways: Development of multiparameter evidence synthesis methodology (T3/9)
  Prof A Sutton
Application Deadline: 5 December 2019

Funding Type

PhD Type

Genetic based information is increasingly being used in screening and diagnostic contexts often used alongside more traditional types of diagnostic medical tests.
  Precision Medicine DTP – Development of clinically relevant models of undifferentiated pleomorphic sarcoma using a genetic screening approach
  Research Group: Edinburgh Cancer Research Centre
  Prof V Brunton, Dr L Boulter, Dr M Taylor, Prof D M Salter
Application Deadline: 8 January 2020

Funding Type

PhD Type

Background. Sarcomas are relatively uncommon cancers thought to arise from pluripotent mesenchymal stem cells. Undifferentiated pleomorphic soft tissue sarcoma (UPS), though one of the commonest sarcoma subtypes encountered, exemplify the limitations of historical progress in sarcoma therapy.
  MRC DiMeN Doctoral Training Partnership: Software, Synthesis and Screening: cheminformatic led invention, design and synthesis of novel compounds for the treatment of septic shock
  Prof JPA Harrity, Dr G Richards, Dr A Hogben, Dr A Pannifer
Application Deadline: 6 January 2020

Funding Type

PhD Type

Industrial and academic medicinal chemists take advantage of modern cheminformatic and biology technologies to inform and guide their science.
  High-throughput discovery of combination therapies and engineering of CRISPR/therapeutic proteins
  Dr A Wong
Applications accepted all year round

Funding Type

PhD Type

Our lab is interested in developing and applying state-of-the-art combinatorial genetics technologies to decipher the mechanisms behind complex diseases, including cancers and neurodegenerative disorders, and discover novel combination therapies.
  Development of an inhalable anti-tubercular therapies to include pre-clinical screening and 3D printing/additive manufacturing.
  Prof S Cryan, Prof A Heise, Dr J Keane
Application Deadline: 2 December 2019

Funding Type

PhD Type

Mycobacterium tuberculosis (TB) is the primary infectious disease killer in the world. In 2016 alone 1.7million people died from TB and 10 million people fell ill [1].
  Evaluation of ex vivo screening methodology
  Dr S Danson, Prof T Helleday
Applications accepted all year round

Funding Type

PhD Type

Cancer affects over 14M individuals worldwide each year and in the UK only 50% of patients have a 10 year survival following cancer diagnosis.
  Genome and transcriptome sequencing and functional analysis to find new mutation types in patients with inherited blindness
  Prof C Inglehearn
Applications accepted all year round

Funding Type

PhD Type

Human inherited retinal dystrophies (IRDs) result from mutations in over 200 different genes, many of them first implicated by the Leeds Vision Research Group (eg Panagiotou E et al 2017, AJHG 100:960-968; El-Asrag M et al 2015, 96:948-54).
  Advanced diagnostics for rapid grading/screening of electric vehicle batteries
  Dr O Curnick
Application Deadline: 13 January 2020

Funding Type

PhD Type

Coventry University (CU) is inviting applications from suitably-qualified graduates for a (fully-funded) PhD studentship. This project encompasses battery diagnostics, battery management systems and vehicle network communication, industrial process integration and quality control.
  Modelling Neurocristopathies in Xenopus, mechanisms and drug screening (WHEELERGU19MCETN1)
  Dr G N Wheeler
Application Deadline: 16 December 2019

Funding Type

PhD Type

NEUcrest is an Innovative Training Network (ITN) project, funded by the European Union Horizon 2020 Programme.
  Next-generation protein engineering: integration of ab-initio modelling, high-throughput screening and structural fingerprinting by mass spectrometry.
  Research Group: BBSRC White Rose DTP
  Dr E Paci, Dr D Tomlinson, Prof F. Sobott
Application Deadline: 6 January 2020

Funding Type

PhD Type

Recombinant proteins are playing an ever-increasing role as therapeutics and reagents in biotechnology. Rationally engineering proteins requires understanding of the principles behind protein interactions.
  Screening of chemical libraries using iPS models for investigating the role of prion protein in Alzheimer’s disease
  Prof B Chen
Applications accepted all year round

Funding Type

PhD Type

Background. AD has been identified as a protein misfolding disease (proteopathy). The disease is caused by accumulation of two major amyloids.
  (BBSRC DTP CASE) Intelligent Engineering of Bacterial Genomes
  Prof R Breitling, Prof E Takano
Application Deadline: 31 January 2020

Funding Type

PhD Type

The goal of this project is to establish methodology for the intelligent engineering of biological hosts for the production of high-value drugs and chemicals.
  Four-year EngD scholarship with the National Composites Centre: Exploitation of Novel Material Technologies (ExMaT)
  Prof IK Partridge
Application Deadline: 31 December 2019

Funding Type

PhD Type

Faculty/School/Department. Faculty of Engineering (University of Bristol). Location. National Composites Centre, Bristol (BS16 7FS).
  Cloning and expression of topoisomerase genes from Trypanosoma brucei (SteverdingD-2U19SF)
  Dr D Steverding
Application Deadline: 31 May 2020

Funding Type

PhD Type

Topoisomerases (TOPs) are essential enzymes that catalysis topological changes in DNA. TOPs are pivotal to cell survival and therefore inhibitors have been developed to target these enzymes both for antimicrobial and anti-cancer chemotherapy.
  EASTBIO A synthetic biology approach to design ‘intelligent’ organoids for the study of host-microbe interactions
  Research Group: Institute of Quantitative Biology, Biochemistry and Biotechnology
  Dr E Cachat, Dr L Boulter
Application Deadline: 5 January 2020

Funding Type

PhD Type

Organoids are self-organised, 3D structures generated in vitro from adult or pluripotent stem cells, that exhibit similar functionality as their tissue of origin.
  Precision Medicine DTP - Analysis of intestinal metagenomes using ASAR
  Prof I Goryanin, Dr S Farrington, Prof M Dunlop
Application Deadline: 8 January 2020

Funding Type

PhD Type

Additional Supervisors. Dr Anatoly Sorokin & Dr Vidya Rajasekaran. Background. Understanding risk factors to Colorectal Cancer (CRC) can aid in its prevention.
  High-throughput discovery of novel antibiotics using synthetic microbiology
  Dr R Draheim
Applications accepted all year round

Funding Type

PhD Type

Antimicrobial resistance (AMR) is a frequent problem in the treatment of disease caused by several clinical bacterial pathogens. In the European Union, antibiotic-resistant infections kill nearly 25,000 patients and represent a total expenditure of £1.5 billion per year.
  High-throughput mechanobiology
  Dr C Toseland
Applications accepted all year round

Funding Type

PhD Type

Cancer research has traditionally focused upon extra- or intra-cellular biochemical signals, and their relation to cancer development and metastasis.
  Defining novel regulators of cancer cell invasion
  Prof M Parsons, Prof J Marshall
Application Deadline: 29 November 2019

Funding Type

PhD Type

The cytoskeleton of cells is known to be essential to the behaviour of cancer cells and their ability to invade throughout the body.
  PhD in Computing - Detection and Amplification of Cancer Biomarkers through DNA Computing
  Dr H Fellermann
Application Deadline: 30 November 2019

Funding Type

PhD Type

Number of awards. 1. Start date and duration. 6 January 2020, full-time for 3 years. Overview. The Interdisciplinary Computing and Complex Biosystems Research Group and Nanovery Ltd.
  Emerging Infectious Diseases – Surveillance and Biosecurity
  Dr N Marks, Dr P McVeigh
Application Deadline: 16 December 2019

Funding Type

PhD Type

Project details. A continued increase in both the geographical range of existing pathogens and the transmission of novel pathogens into the human population poses a challenge for the effective control of emerging infectious diseases (EIDs) and biosecurity.
  Computer Simulations of G protein-coupled Receptors
  Dr I Tikhonova
Applications accepted all year round

Funding Type

PhD Type

Many physiological processes are controlled through the activation of G protein-coupled receptors (GPCRs) by regulatory peptides, making peptide GPCRs particularly useful targets for major human diseases such as diabetes and CNS diseases.
  Pharmacoengineering of advanced RNA-nanomedicines to treat cystic fibrosis (CF)
  Prof S Cryan, Prof A Heise, Prof C Greene
Application Deadline: 2 December 2019

Funding Type

PhD Type

Cystic fibrosis (CF) is an inherited disorder caused by a mutation in a single gene responsible for the production of a protein called the cystic fibrosis transmembrane conductance regulator (CFTR).
  Exploiting druggability host spots in protein phosphatase targets
  Dr L Tabernero, Prof D Procter, Dr S Butterworth
Applications accepted all year round

Funding Type

PhD Type

In the past years the use of virtual screening or computer-based screening of compound libraries against selected targets has expanded exponentially the boundaries of drug discovery.
  What is the best way for healthcare professionals to communicate changes in estimated risk of breast cancer?
  Prof D French, Prof G Evans
Applications accepted all year round

Funding Type

PhD Type

Risk estimation models for common multifactorial diseases such as breast cancer are often used, e.g. in Family History Clinics to inform decisions about prevention options.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.